Skip to content
ChickenStockChickenStock
ResearchHCA
HCA Healthcare logo

HCA Healthcare (HCA) stock

NYSE

$499.05-0.32%(-1.60)

As of the Nov 13, 2026 close (U.S. Eastern)

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

15.39x

P/B

—

P/S

1.33x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Revenue increased 3.6% from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Oct 29, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

28 SEC filings
  • Rossitto EricaSVP & Chief Nurse Executive · Nov 10, 2026Open-market sale3,500 shares · $1.8M
    Avg. price $505.810113,426 shares held after
  • Foster Jon MEVP and COO · Nov 6, 2026Open-market sale21,713 shares · $10.7M
    Avg. price $494.947
    Show 7 price lots
    • 7,595 shares × $494.9145$3.8M
    • 6,302 shares × $493.5795$3.1M
    • 2,692 shares × $495.8541$1.3M
    • 1,684 shares × $497.9984$839K
    • 1,484 shares × $491.9817$730K
    • 1,066 shares × $496.9199$530K
    • 890 shares × $498.971$444K
  • Rossitto EricaSVP & Chief Nurse Executive · Nov 6, 2026Shares withheld for taxes6,601 shares · $3.3M
    Avg. price $494.9916,926 shares held after
  • Rossitto EricaSVP & Chief Nurse Executive · Nov 6, 2026Option exercise13,120 shares · $1.2M
    Avg. price $89.3356
    Show 2 price lots
    • 8,080 shares × $81.96$662K
    • 5,040 shares × $101.16$510K
  • Foster Jon MEVP and COO · Nov 4, 2026Open-market sale10,000 shares · $5.1M
    Avg. price $514.06980 shares held after
  • Schlosser Michael JEVP and Chief Clinical Officer · Nov 4, 2026Open-market sale1,200 shares · $594K
    Avg. price $494.65241,443 shares held after
  • Elcan Patricia F10% owner · Nov 4, 2026Other1,773,742 shares · $893.1M
    Avg. price $503.52532,282,889 shares held after
    Show 2 price lots
    • 886,871 shares × $503.525$446.6M
    • 886,871 shares × $503.525$446.6M
  • FRIST THOMAS F IIIDirector · Nov 4, 2026Other1,111,000 shares · $559.4M
    Avg. price $503.52532,282,889 shares held after
    Show 2 price lots
    • 555,500 shares × $503.525$279.7M
    • 555,500 shares × $503.525$279.7M
  • Foster Jon MEVP and COO · Nov 4, 2026Shares withheld for taxes20,309 shares · $10.4M
    Avg. price $510.715,571 shares held after
  • Foster Jon MEVP and COO · Nov 4, 2026Other16,142 shares · $8.1M
    Avg. price $503.52551,453 shares held after
  • Foster Jon MEVP and COO · Nov 4, 2026Option exercise35,880 shares · $5.2M
    Avg. price $145.2435,880 shares held after
  • Marks Mike AEVP and CFO · Nov 2, 2026Other1,042 shares · $489K
    Avg. price $469.40525,458 shares held after
  • Marks Mike AEVP and CFO · Nov 2, 2026Gift1,042 shares · $0
    Avg. price $02,298 shares held after
  • Marks Mike AEVP and CFO · Oct 30, 2026Shares withheld for taxes2,287 shares · $1.1M
    Avg. price $473.192,298 shares held after
  • Marks Mike AEVP and CFO · Oct 30, 2026Option exercise4,585 shares · $376K
    Avg. price $81.964,585 shares held after
  • Schlosser Michael JEVP and Chief Clinical Officer · Oct 29, 2026Shares withheld for taxes2,455 shares · $1.2M
    Avg. price $478.082,643 shares held after
  • Schlosser Michael JEVP and Chief Clinical Officer · Oct 29, 2026Option exercise4,928 shares · $406K
    Avg. price $82.3028
    Show 2 price lots
    • 3,030 shares × $81.96$248K
    • 1,898 shares × $82.85$157K
  • McAlevey Michael REVP & Chief Legal & Admin Off. · Aug 26, 2026Other7,769 shares · $3.3M
    Avg. price $4290 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

HCA Healthcare (HCA) stock information

NYSE

HCA Healthcare (HCA) is listed on NYSE. Its market capitalization is about $104.3B. On trailing-twelve-month earnings the P/E ratio is 15.39. These figures are computed in-house from official filings and are reference information only.

HCA Healthcare — frequently asked questions

What is the P/E ratio of HCA Healthcare (HCA)?
On a trailing-twelve-month basis, HCA trades at a P/E ratio of 15.39. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of HCA Healthcare?
HCA has a market capitalization of about $104.3B. The figure moves with the share price and is refreshed each trading day.
Does HCA Healthcare pay a dividend?
HCA has a dividend yield of about 0.58%, based on disclosed payment history. Dividend policy can change; this is reference information only.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.